The global antivenom market is expected to reach US$ 3010.8 Mn by 2025. Antivenom, also known as antivenom immunoglobulin, antivenin, and venom antiserum.
The global anthrax vaccine market is expected to reach US$ 845.7 Mn by 2025. Anthrax is caused by the bacterium Bacillus anthracis is a deadly human disease that also infects animals like horse, sheep, cattle and goats.